The GHS-R Blocker D-[Lys3] GHRP-6 Serves as CCR5 Chemokine Receptor Antagonist

@article{Patel2012TheGB,
  title={The GHS-R Blocker D-[Lys3] GHRP-6 Serves as CCR5 Chemokine Receptor Antagonist},
  author={Kalpesh Patel and V. Dixit and J. Lee and J. W. Kim and E. M. Schaffer and Dzung Nguyen and D. Taub},
  journal={International Journal of Medical Sciences},
  year={2012},
  volume={9},
  pages={51 - 58}
}
  • Kalpesh Patel, V. Dixit, +4 authors D. Taub
  • Published 2012
  • Biology, Medicine
  • International Journal of Medical Sciences
  • [D-Lys3]-Growth Hormone Releasing Peptide-6 (DLS) is widely utilized in vivo and in vitro as a selective ghrelin receptor (GHS-R) antagonist. This antagonist is one of the most common antagonists utilized in vivo to block GHS-R function and activity. Here, we found that DLS also has the ability to modestly block chemokine function and ligand binding to the chemokine receptor CCR5. The DLS effects on RANTES binding and Erk signaling as well as calcium mobilization appears to be much stronger… CONTINUE READING
    21 Citations
    [D-Lys3]-GHRP-6 exhibits pro-autophagic effects on skeletal muscle
    • 6
    • Highly Influenced
    Ablation of ghrelin receptor in leptin-deficient ob/ob mice has paradoxical effects on glucose homeostasis when compared with ablation of ghrelin in ob/ob mice.
    • X. Ma, Yuezhen Lin, +5 authors Y. Sun
    • Chemistry, Medicine
    • American journal of physiology. Endocrinology and metabolism
    • 2012
    • 29
    • PDF
    CHEMOKINE RECEPTORS IN HIV INFECTION
    Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway.
    • 44
    • PDF

    References

    SHOWING 1-10 OF 22 REFERENCES
    Development of growth hormone secretagogues.
    • R. Smith
    • Biology, Medicine
    • Endocrine reviews
    • 2005
    • 140
    • PDF
    Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells.
    • 748
    • PDF
    A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.
    • M. Baba, O. Nishimura, +9 authors M. Fujino
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 1999
    • 748
    • PDF
    Ghrelin: structure and function.
    • 1,453
    • PDF
    The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention.
    • 83
    Antagonism of ghrelin receptor reduces food intake and body weight gain in mice
    • 452
    • PDF
    AIDS-related insulin resistance and lipodystrophy syndrome.
    • T. Kino, G. Chrousos
    • Medicine
    • Current drug targets. Immune, endocrine and metabolic disorders
    • 2003
    • 20
    The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.
    • 32
    • Highly Influential